Ledger.Open graph →
SEC Form D · filed March 27, 2026

Apnimed, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Brian W. Hurley · New York, NYDirectorCraig W. Ruckman · New York, NYExecTony Adams · Lenexa, KSDirectorAlan Townsend · Lenexa, KSDirectorDavid C. Owen · Lenexa, KSExecBrian Linin · Lenexa, KSDirectorRobert W. Fordi · Annapolis, MDExec · DirectorKenneth S. Code · Annapolis, MDDirectorZaiqing Zhu · New York, NYDirectorMichael L. Jones · DALLAS, TXDirectorCarl Perez · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗